Clinical ShowCase: Next Best Steps in Managing EDS in OSA

Release Date: July 24, 2020
Expiration Date: July 24, 2021

Activity Overview

This online activity is designed to provide concise and easy-to-digest education in an engaging and interactive case-based format. The case focuses on diagnosing excessive daytime sleepiness in patients with obstructive sleep apnea and choosing the most appropriate therapy based on the clinical scenario. The engaging format of this program includes interactive clinical decision points with explanations at the end of the activity, and an evidence-based review supporting the teaching points covered in the case.

Acknowledgement of Support

This activity is supported by educational grants from Jazz Pharmaceuticals, Inc.

Target Audience

This educational activity is directed toward sleep specialists, including, neurologists, psychiatrists, and pulmonologists; primary care providers; nurse practitioners; physician assistants; and other health care professionals involved in the care of patients with excessive daytime sleepiness (EDS )in patients with obstructive sleep apnea (OSA).

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

• Describe diagnostic methods to determine the presentation and severity of excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA)
• Select next steps in care for patients with EDS in OSA based on current and emerging treatment options

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Richard K. Bogan, MD, FCCP, FAASM
President
Bogan Sleep Consultants LLC
Columbia, SC
Chief Medical Officer
Sleepmed
Columbia, SC

Disclosures: Grant/Research Support: Idorsia, Jazz, Harmony, Suven, Merck, Philips, Fresca. Consultant: Jazz, Takeda, Hamony. Speaker's Bureau: Jazz, Harmony, Eisai. Stock/Shareholder: SinuSonic, Watermark Medical, Inc.

Laura B. Herpel, MD
Bogan Sleep Consultants
Columbia, SC

Disclosures: Grant/Research Support: Jazz, Idorsia, Fresca, Oventus, Takeda, Suven.

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.